Revna Biosciences
PrivateLast Round
Growth Equity
Mar 1, 2026
Total Funding Raised
$118,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Revna Biosciences is a biotechnology company that provides precision medicine services, advanced molecular diagnostics, and biobanking infrastructure in Africa.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Usage-Based SaaS, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Revna Biosciences Comparables
Compare Revna Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Yemaachi Biotechnology | 84% | |
| Pahtia Technologies | 63% | |
| Roche Holding | 63% |
Revna Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Growth Equity | Mar 1, 2026 | ||||
| VC Round | Dec 1, 2024 | ||||
| Grant | Mar 27, 2024 | ||||
| Grant | Aug 24, 2023 | ||||
| Seed | Nov 11, 2022 |
Revna Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Aruwa Capital Management | VC Round |
| Jaza Rift Ventures | Seed |
| African Diaspora Network | Seed, Grant |
| develoPPP Ventures | Grant |
| Mirepa Capital | Growth Equity |
| develoPPP | Grant |
| Tekedia Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 55% MoM, reaching 1K.
- Jul 25, 2026
Monthly visitors increased 31% MoM.
Recent news
Latest coverage and updates
- launchesAug 26, 2026
RevnaBio launched LifeReady DNA Test on Aug 26th '26.
Revna Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Revna Biosciences's valuation, stock price, and market status.
Is Revna Biosciences a public or private company?
Revna Biosciences is a private company.
What is the current stock price of Revna Biosciences?
Revna Biosciences is a private company with no public stock price. No recent secondary market data is available.
How much is Revna Biosciences worth (valuation)?
Valuation information for Revna Biosciences is not publicly available.
Can I buy Revna Biosciences stock?
Revna Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Revna Biosciences's last funding round?
Revna Biosciences's most recent funding round was Early Funding on March 1, 2026.
Who are the main investors in Revna Biosciences?
Key investors in Revna Biosciences include develoPPP.
Will Revna Biosciences IPO soon?
No public IPO plans have been announced for Revna Biosciences.
How can I track Revna Biosciences secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Revna Biosciences's secondary market activity and sign up for updates.